You are here

  • Home
  • Archive
  • Volume 32, Issue 1
  • ADAGIO: a phase IIb international study of the Wee1 inhibitor adavosertib in women with recurrent or persistent uterine serous carcinoma

Article metrics

Article menu
Download PDFPDF
Clinical trial
ADAGIO: a phase IIb international study of the Wee1 inhibitor adavosertib in women with recurrent or persistent uterine serous carcinoma

 

Online download statistics by month:

Online download statistics by month: October 2021 to February 2023

AbstractFullPdf
Oct 202135521
Nov 20218521714
Dec 2021432910
Jan 20229922519
Feb 202215251413
Mar 2022249135
Apr 202218756
May 2022246811
Jun 2022374138
Jul 202222694
Aug 202215252
Sep 202219756
Oct 202219696
Nov 202215963
Dec 202213233
Jan 202313900
Feb 20232221
Total6435145112